Literature DB >> 35072774

A novel EWSR1-HOXB13 rearrangement in a fibroblastic tumor from the abdomen of a young woman.

Harumi Nakamura1, Yoji Kukita2, Hironari Tamiya3, Satoshi Takenaka3, Toshinari Yagi4.   

Abstract

We describe a novel EWSR1-HOXB13-fusion in a fibroblastic tumor from the abdominal wall of a 29-year-old woman. This tumor caused intermittent intense pain and had grown to approximately 5 cm in size over two years. The tumor was located beneath subfascial section of the abdominal wall and was invading the abdominal cavity and pressing on the liver. The tumor was well-circumscribed and consisted of intersected fascicles of monomorphic spindle-shaped cells with uniform ovoid nuclei lacking nuclear pleomorphism or mitotic activity. This tumor was immunohistochemically negative for pan-cytokeratin AE1/AE3, desmin, SMA, S100, myogenin, MyoD1, CD34, melanosome, SOX10, STAT6, SS18-SSX, and ERG. H3K27me3 was retained. RNA sequencing revealed a unique EWSR1-HOXB13-fusion, and strong, diffuse nuclear immunostaining for HOXB13 was observed. No local recurrence or evident distant metastasis were observed over eight months without chemotherapy, implying that the behavior of this tumor is not yet known.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  EWSR1-HOXB13-fusion; Fibroblastic spindle cell tumor; Immunohistochemistry; RNA sequencing

Mesh:

Substances:

Year:  2022        PMID: 35072774     DOI: 10.1007/s00428-022-03282-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  8 in total

1.  EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.

Authors:  Michael Michal; Ryan S Berry; Brian P Rubin; Scott E Kilpatrick; Abbas Agaimy; Dmitry V Kazakov; Petr Steiner; Nikola Ptakova; Petr Martinek; Ladislav Hadravsky; Kvetoslava Michalova; Zoltan Szep; Michal Michal
Journal:  Am J Surg Pathol       Date:  2018-10       Impact factor: 6.394

2.  Novel EWSR1-SMAD3 Gene Fusions in a Group of Acral Fibroblastic Spindle Cell Neoplasms.

Authors:  Yu-Chien Kao; Uta Flucke; Astrid Eijkelenboom; Lei Zhang; Yun-Shao Sung; Albert J H Suurmeijer; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2018-04       Impact factor: 6.394

3.  Novel NTRK3 Fusions in Fibrosarcomas of Adults.

Authors:  Fumito Yamazaki; Fumihiko Nakatani; Naofumi Asano; Susumu Wakai; Masaya Sekimizu; Sachiyo Mitani; Takashi Kubo; Akira Kawai; Hitoshi Ichikawa; Akihiko Yoshida
Journal:  Am J Surg Pathol       Date:  2019-04       Impact factor: 6.394

4.  Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Authors:  Arjen H G Cleven; Ghadah A Al Sannaa; Inge Briaire-de Bruijn; Davis R Ingram; Matt van de Rijn; Brian P Rubin; Maurits W de Vries; Kelsey L Watson; Keila E Torres; Wei-Lien Wang; Sjoerd G van Duinen; Pancras C W Hogendoorn; Alexander J Lazar; Judith V M G Bovée
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

5.  Modulation of the human homeobox genes PRX-2 and HOXB13 in scarless fetal wounds.

Authors:  E J Stelnicki; J Arbeit; D L Cass; C Saner; M Harrison; C Largman
Journal:  J Invest Dermatol       Date:  1998-07       Impact factor: 8.551

6.  FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.

Authors:  Malin Lindén; Christer Thomsen; Pernilla Grundevik; Emma Jonasson; Daniel Andersson; Rikard Runnberg; Soheila Dolatabadi; Christoffer Vannas; Manuel Luna Santamarίa; Henrik Fagman; Anders Ståhlberg; Pierre Åman
Journal:  EMBO Rep       Date:  2019-04-08       Impact factor: 8.807

Review 7.  EWSR1-The Most Common Rearranged Gene in Soft Tissue Lesions, Which Also Occurs in Different Bone Lesions: An Updated Review.

Authors:  Uta Flucke; Max M van Noesel; Vasiliki Siozopoulou; David Creytens; Bastiaan B J Tops; Joost M van Gorp; Laura S Hiemcke-Jiwa
Journal:  Diagnostics (Basel)       Date:  2021-06-15

8.  A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma.

Authors:  Esther Baranov; Matthew J McBride; Andrew M Bellizzi; Azra H Ligon; Christopher D M Fletcher; Cigall Kadoch; Jason L Hornick
Journal:  Am J Surg Pathol       Date:  2020-07       Impact factor: 6.298

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.